Clinical Trials Logo
  1. Home
  2. Hyperprolactinemia
  3. NCT02603549

Pituitary Function and Spontaneous Intracranial Hypotension

Hyperprolactinemia Clinical Trial

Official title:
Spontaneous Spinal Cerebrospinal Fluid Leaks and Intracranial Hypotension

Clinical Trial Summary

Previous research has identified spontaneous cerebral spinal fluid leakage as a cause for spontaneous intracranial hypotension, leading to positional headache patterns. Typical magnetic resonance imaging findings include subdural fluid collections, enhancement of pachymenginges, engorgement of venous structures, pituitary hyperemia, and sagging of the brain (SEEPS). Because pituitary hyperemia has been documented in cases of spontaneous cerebral spinal fluid leakage and is known to mimic a pituitary tumor or hyperplasia, the investigators would like to like to assess the clinical manifestations and neuroimaging abnormalities of SIH patients with regard to the pituitary gland. Specifically, the investigators are looking to analyze the compression of the pituitary stalk and conduct a systemic evaluation of pituitary function in SIH patients.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02603549
Study type Observational
Source Cedars-Sinai Medical Center
Contact
Status Suspended
Phase
Start date July 2015
Completion date December 2020
View Details
See also
  Status Clinical Trial Phase
Completed NCT03569787 - Hyperprolactinaemia Management in Reproductive Services at University Hospital of Coventry and Warwickshire
Completed NCT02098668 - Mathematical Model for the Human Menstrual Cycle, Endocrinological Diseases and Fertility Treatment-PAEON N/A
Completed NCT03038308 - Treatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist Ropinirole Phase 1/Phase 2
Not yet recruiting NCT00541554 - Reversal of Antipsychotic-Induced Hyperprolactinemia, Weight Gain, Hyperglycemia and Dyslipidemia Phase 4
Completed NCT01270711 - Study On Utilization Of Cabergoline For Compliance With Risk Minimization Activities (SUCRE) N/A
Completed NCT02956447 - Administration of Kisspeptin in Patients With Hyperprolactinemia Phase 2
Recruiting NCT05033119 - PROSA: Prolactin, Sex Hormones, Growth and Metabolic Biomarkers in Children and Adolescents on Antipsychotics
Completed NCT06326840 - Clinical Efficacy and Adverse Reactions of Antipsychotic Treatment N/A
Withdrawn NCT00699530 - Substrate Metabolism and Insulin Sensitivity in Patients With Hyperprolactinemia Before and After Treatment N/A
Not yet recruiting NCT00315081 - Risperidone-Induced Hyperprolactinemia Treated With Bromocriptine Phase 3
Recruiting NCT04746313 - Prevalence of Hyperprolactinemia in Systemic Scleroderma
Terminated NCT04146389 - Hyperprolactinemia and Adrenal Steroidogenesis
Recruiting NCT00914823 - Kisspeptin Administration in the Adult Phase 1
Completed NCT01852331 - Peony-Glycyrrhiza Decoction (PGD) for Antipsychotic-induced Hyperprolactinemia in Patients With Schizophrenia Phase 2
Completed NCT01338298 - Double-Blind Placebo Controlled Study of Adjunctive Aripiprazole for Symptomatic Hyperprolactinemia In Premenopausal Women With Schizophrenia N/A
Completed NCT01052948 - The Association Between Dopamine Agonists and Cardiac Valvulopathy, Fibrosis and Other Cardiopulmonary Events N/A
Completed NCT00436111 - Characterization of Macroprolactinemia N/A
Active, not recruiting NCT04439747 - Develop and Implement Methods for Diagnostic and Treatment of Hormonal Disorders in Patients With Chronic Kidney Disease
Recruiting NCT01742390 - A Multicenter Study to Evaluate the Effects of Switching to Aripiprazole 12 Weeks on the Sexual Dysfunction From Risperidone or Paliperidone in Patients With Schizophrenia Spectrum Disorders or Bipolar Spectrum Disorders Phase 4
Completed NCT00625950 - Endometriosis Patients Undergoing Quinagolide Treatment Phase 4